Seebio ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Estimate generation in progress, please wait...
Loading...

Loading...

Loading...

Loading...

   
Loading...

Bankruptcy Risk 
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  15.0% 14.1% 11.3% 12.7% 20.6%  
Credit score (0-100)  15 17 21 17 4  
Credit rating  B B B B C  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12

Net sales  0 0 7 0 0  
Gross profit  0.0 0.0 -2.1 -1.7 -21.0  
EBITDA  0.0 0.0 -3.3 -5.3 -23.9  
EBIT  0.0 0.0 -3.3 -5.3 -23.9  
Pre-tax profit (PTP)  2.3 2.8 -0.4 -2.8 -1.9  
Net earnings  2.3 2.1 -1.0 -2.8 -1.9  
Pre-tax profit without non-rec. items  2.3 2.8 -0.4 -2.8 -1.9  

 
See the entire income statement

Balance sheet (kDKK) 
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  171 231 364 363 353  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  171 231 364 363 353  

Net Debt  -171 -231 -364 -363 -353  
 
See the entire balance sheet

Volume 
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12

Net sales  0 0 7 0 0  
Net sales growth  0.0% 0.0% 0.0% -100.0% 0.0%  
Gross profit  0.0 0.0 -2.1 -1.7 -21.0  
Gross profit growth  0.0% 0.0% 0.0% 21.1% -1,138.8%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  171 231 364 363 353  
Balance sheet change%  1.6% 35.3% 57.2% -0.1% -3.0%  
Added value  0.0 0.0 -3.3 -5.3 -23.9  
Added value %  0.0% 0.0% -49.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 -1.0 0.0  
EBIT trend  0.0 0.0 -1.0 -2.0 -3.0  

Profitability 
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
EBITDA %  0.0% 0.0% -49.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% -49.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% 154.1% 311.3% 113.7%  
Net Earnings %  0.0% 0.0% -15.3% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% -15.3% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% -5.8% 0.0% 0.0%  
ROA %  1.3% 1.4% -0.1% -0.8% -0.5%  
ROI %  1.3% 1.4% -0.1% -0.8% -0.5%  
ROE %  1.3% 1.1% -0.3% -0.8% -0.5%  

Solidity 
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
Equity ratio %  100.0% 100.0% 100.0% 100.0% 100.0%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% -5,394.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% 11,000.0% 6,888.2% 1,477.3%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
Quick Ratio  0.0 0.0 0.0 0.0 0.0  
Current Ratio  0.0 0.0 0.0 0.0 0.0  
Cash and cash equivalent  171.0 231.4 363.8 363.3 352.5  

Capital use efficiency 
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 5,394.0% 0.0% 0.0%  
Net working capital  6.3 8.3 8.2 6.5 6.9  
Net working capital %  0.0% 0.0% 121.7% 0.0% 0.0%  

Employee efficiency 
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0